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A B S T R A C T
The increasing resistance of pathogen fungi poses a global public concern. There are several limitations in
current antifungals, including few available fungicides, severe toxicity of some fungicides, and drug resistance.
Therefore, there is an urgent need to develop new antifungals with novel targets. Chitosan has been recognized
as a potential antifungal substance due to its good biocompatibility, biodegradability, non-toxicity, and avail-
ability in abundance, but its applications are hampered by the low charge density results in low solubility at
physiological pH. It is believed that enhancing the positive charge density of chitosan may be the most effective
approach to improve both its solubility and antifungal activity. Hence, this review mainly focuses on the
structural optimization strategy of cationic chitosan and the potential antifungal applications. This review also
assesses and comments on the challenges, shortcomings, and prospect of cationic chitosan derivatives as anti-
fungal therapy.
1. Introduction
1.1. Global human health and food security threats from fungal resistance
Although the harmfulness of viruses and bacteria is more notice-
able, fungi are invisible killers that should never be ignored. In fact,
fungi account for most of the recorded global and regional extinctions
of all tracked pathogens, and they continue to threaten threatening
humans and crops (Goffeau, 2008; Hahn, 2014). Today, the current
global mortality rate of fungal diseases now exceeds that of malaria or
breast cancer, which is comparable to that of HIV (Brown et al., 2012;
Fisher, Hawkins, Sanglard, & Gurr, 2018). Additionally, phytopatho-
genic fungi cause crop yield reductions of about 20 % worldwide, and
further losses of more than 10 % postharvest (Fisher et al., 2012). To
date, fungal infections have apparently been largely ignored compared
to other types of pathogenic microorganisms, despite their ubiquitous
fungal diseases.
The use of antifungal agents is considered as one of the most ef-
fective way to reduce and prevent fungal infections. However, the ex-
tensive use of chemical fungicides now has led to the increasing re-
sistance of microorganisms, which poses a global public concern
(Baker, 2015; Fisher et al., 2018; Monk & Goffeau, 2008; Revie, Iyer,
Robbins, & Cowen, 2018).
Most recently, the Centers for Disease Control and Prevention (CDC)
of USA warned of a potentially deadly drug-resistant superbug fungus
called Candida auris, which considers the fungus a "serious global health
threat" (Meis & Chowdhary, 2018; Rhodes & Fisher, 2019; Welsh,
Sexton, Forsberg, Vallabhaneni, & Litvintseva, 2019). The emergence of
resistant strains of fungi is making traditional antibiotic-based therapies
less effective. What's worse is that the lag in the development of new
antifungal agents make the treatment of fungi face a state of almost no
drug availability. Therefore, the prevention and control of pathogenic
fungi is becoming increasingly difficult and challenging (Baker, 2015;
Fisher et al., 2018; Roope et al., 2019). To address this problem, it is
urgently critical to develop new antifungals with high selectivity and
novel mechanisms. Thus, there has been considerable interest in the
study of the potential application of antimicrobial polymers for fungal
disease control in the clinic and the field. Antimicrobial polymers have
emerged as ideal candidates to inhibit the spread of antibiotic-resistant
infections because of their broad-spectrum antifungal activity, non-
specific mechanisms, and long-term efficacy (Ergene, Yasuhara, &
Palermo, 2018; Muñoz-Bonilla & Fernández-García, 2012; Timofeeva &
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Kleshcheva, 2011). Among these antimicrobial polymers, chitosan, as a
kind of marine biological polysaccharide with good biocompatibility
and non-toxicity, has attracted much attention for antimicrobial ap-
plications (Casettari et al., 2012; Chuan, Jin, Fan, Zhou, & Guo, 2019;
Pillai, Paul, & Sharma, 2009; Shariatinia, 2019).
1.2. The fungistatic and fungicidal mechanism of chitosan and its relation
with the induced resistance
Chitosan, the deacetylated derivative of chitin, is a linear poly-
saccharide of β-(1, 4)-linked N-acetylglucosamine, which is mainly
obtained from the waste products of crab and shrimp shells. It has been
proven that chitosan has broad-spectrum antimicrobial activity, can
inhibit the growth of a variety of fungi, bacteria and yeasts (Bautista-
Baños et al., 2006; Rabea, Badawy, Stevens, Smagghe, & Steurbaut,
2003). There is no doubt that chitosan is a potential antimicrobial
substance due to its good biocompatibility, biodegradability, non-
toxicity, and availability in abundance. As early as 1979, chitosan was
proved to have broad-spectrum activity against various fungi (Allan &
Hadwiger, 1979). Generally, chitosan has been reported to be very ef-
fective in inhibiting spore germination, germ tube elongation, and ra-
dial growth (Bautista-Baños et al., 2006). What is more interesting is
the generally recognized view that fungi such as yeasts and moulds are
more sensitive to chitosan than Gram-negative and Gram-positive
bacteria (Badawy & Rabea, 2011; Roller & Covill, 1999). The antifungal
activity of chitosan is mostly considered to be fungistatic, rather than
fungicidal. For example, it is reported that the antifungal mechanism
for A. parasiticus is mainly fungistatic, and it is attributed to the high
Mw value of the chitosan sample used (Cota-Arriola et al., 2011).
However, this view remains controversial. In contrast, some researchers
stated that chitosan has expressed fungicidal activity and can com-
pletely inhibit certain fungi including F. oxysporum, R. stolonifer, Peni-
cillium digitatum, and C. albicans (Bautista-Baños, Hernández-López,
Bosquez-Molina, & Wilson, 2003; Bautista-Baños, Hernández-López, &
Bosquez-Molina, 2004). Whether chitosan exhibits fungistatic or fun-
gicidal effects. It is now recognized that the electrostatic interaction of
protonated amino groups of chitosan on the cell surface of fungal is the
key to endow it the ability to bind, alter or destroy microbial cell sur-
face. The biggest difference between the two mechanisms may be that
the fungistatic effect is recoverable and reversible, while the fungicidal
effect is destructive and irreversible, which is distinct from the tradi-
tional low molecular weight antimicrobials (Galván Márquez et al.,
2013; Kong, Chen, Xing, & Park, 2010; Raafat, von Bargen, Haas, &
Sahl, 2008; Rabea et al., 2003; Verlee, Mincke, & Stevens, 2017).
Chitosan is considered an ideal antifungal candidate due to its non-
specific mechanism of pathogen suppression. It primarily targets mi-
crobial cell walls / cell membranes and shows a less tendency to trigger
the development of drug resistance (Rabea et al., 2003; Verlee et al.,
2017; Xing et al., 2018). Developing resistance to chitosan may require
fungi to dramatically alter their cell surface structures. In this direction,
various chitosan-based antimicrobial strategies have emerged, which
can provide promising solutions to this global problem of drug re-
sistance.
However, chitosan is a weak class of polyamine with a pKa of
around 6.5, which imparts pH-responsiveness. Chitosan shows anti-
fungal activity only under acidic conditions. The low charge density
results in low solubility at physiological pH, aggregation of chitosan
and instability of chitosan-based formulations (Mao, Sun, & Kissel,
2010; Szymańska & Winnicka, 2015). In addition, its antifungal activity
is far from satisfactory compared with that of traditional fungicides.
These factors greatly limit the practical application of chitosan.
Fortunately, it is easy to chemically modify chitosan to improve its
physical characteristics such as solubility and antifungal properties
because of the presence of attractive reactive sites such as hydroxyl and
amino groups in the chitosan backbone. Interestingly, structural mod-
ification generally does not change the basic properties of chitosan
itself, but does introduce new properties. The molecular structure of
chitosan enables it to undergo many reactions, such as cross-linking,
oxidation, reduction, complexation, halogenation, phosphorylation,
acylation, and so on, resulting in different derivatives (Mourya &
Inamdar, 2008; Sahariah & Másson, 2017; Shahid ul & Butola, 2019;
Zargar, Asghari, & Dashti, 2015; Zhang et al., 2010). Among these
derivatives, cationic chitosan derivatives, including quaternary am-
monium salts, have been the most studied. A large number of studies
have shown that enhancing the cationic properties of chitosan can not
only improve its solubility, but also enhance its activity and extend its
applications (Cai et al., 2015; Chethan, Vishalakshi, Sathish, Ananda, &
Poojary, 2013; Hoque et al., 2016; Mohamed, Sabaa, El-Ghandour,
Abdel-Aziz, & Abdel-Gawad, 2013; Sahariah, Másson, & Meyer, 2018;
Wu, Long, Xiao, & Dong, 2016). It is believed that cationic chitosan
derivatives with a permanent positive charge generally have better
antimicrobial ability than chitosan itself.
In the past two decades, the antimicrobial activities of cationic
chitosan derivatives have been extensively studied. In particular, there
are a lot of many papers and some reviews on the antibacterial activities
of cationic chitosan derivatives (Sahariah & Másson, 2017; Verlee et al.,
2017). On the contrary, only a limited number of review articles have
been devoted to the antifungal applications of cationic chitosan deri-
vatives. In particular, it is obvious that the strategies and methods of
chitosan modification in for antifungals have not been completely
concluded and summarized. Therefore, it is necessary to sort out,
summarize and provide perspective regarding research progress on the
antifungal properties of the chitosan derivatives in recent years.
Hence, the focus of this paper is to describe the structural mod-
ification strategy strategies of cationic chitosan and the latest progress
in the antifungal activities and the potential medical and agricultural
applications. At the same time, we will also summarize and discuss the
limitations, challenges and prospects of cationic chitosan derivatives as
antifungal candidates.
2. Strategies for increasing positive charge density of chitosan
Chitosan is abundant in nature and it contains three nucleophilic
functional groups: C2eNH2, C3eOH and C6−OH (Fig. S1 in
Supplementary data). It can be easily modified on at the amino or C6
C6-hydroxyl groups, while it is difficult to react on at the C3−OH
groups is difficult due to the large steric hindrance. Among these
groups, the 2-amino groups are mostly most often chemically modified.
This is mainly due to the good chemical reactivity of the 2-amino group,
which is easy to carry out allows the grafting reaction to be easily
carried out. However, it should be noted that although amino groups of
chitosan are more reactive to have nucleophilic reactions than are hy-
droxyl groups, both active groups can react with electrophilic reagents
such as acids, acyl chlorides, and halogenated alkanes, which may
modify the amino and hydroxyl groups non-selectively (Sahariah &
Másson, 2017; Sashiwa & Aiba, 2004). For example, alkyl halides are
often used to prepare chitosan quaternary ammonium salts, but this
method usually leads to alkylation of C6 hydroxyl group of chitosan
(Rúnarsson, Holappa, Jónsdóttir, Steinsson, & Másson, 2008; Suzuki,
Oda, Shinobu, Saimoto, & Shigemasa, 2000). To address this issue and
obtain chitosan derivatives with high regioselectivity, different pro-
tecting groups can be introduced different protecting groups into C 2
NH2, C3 −OH and C6 −OH. Phthaloyl groups and Schiff bases are
often used to protect the amino group of chitosan (Chen, Tao, Qiu, Ren,
& Hu, 2013; Hu et al., 2016; Kurita, Ikeda, Yoshida, Shimojoh, &
Harata, 2002; Li, Yang, & Yang, 2015), and triphenylmethyl, tri-
methylsilyl and tert-butyldimethylsilyl are commonly used to protect
the hydroxyl groups of chitosan (Benediktsdóttir et al., 2011; Holappa
et al., 2005; Kurita, Sugita, Kodaira, Hirakawa, & Yang, 2005;
Rúnarsson, Malainer, Holappa, Sigurdsson, & Másson, 2008).
It is believed that the positively charged amino group of chitosan is
the key factor affecting its antifungal activity. In the past 2 decades,
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many studies have aimed to improve the activity of chitosan by en-
hancing the positive charge density. Catatonically charged chitosan can
be obtained by various grafting processes, among which, cationic re-
agents are mostly the most commonly used approaches, which are
linked to the chitosan backbone. Therefore, in this review, the most
remarkable cationic chitosans, which are classified as quaternary ni-
trogen atoms, quaternary analogs, polyamines, guanidine, and amino
acids/peptides were, are listed and described below (Fig. S2 in
Supplementary data).
It should be noted that although chitosan exhibits different activities
against fungi and bacteria, the modification strategies are similar to
some extent. Hence, before discussing and summarizing the antifungal
activity and structure-activity relationship of cationic chitosan deriva-
tives, it should be pointed out that the following modification strategies
for improving the cationic properties of chitosan are also common
methods to improve the antibacterial activity of chitosan. Some studies
have also proven that chitosan derivatives containing cationic groups
usually possess both antifungal and bacteriostatic activities (Hassan,
2018; Mohamed & Abd El-Ghany, 2018; Yang, Cai, Hu, Li, & Du, 2012).
2.1. Introducing quaternary ammonium salt groups
Quaternary ammonium compounds (QACs), a class of cationic sur-
factant broad-spectrum fungicides, are widely used in the paint, water
treatment, textile and food industry (Gerba, 2015; Tischer, Pradel,
Ohlsen, & Holzgrabe, 2012). For example, dequalinium chloride and
benzalkonium chloride, well known in the medical field, are typical
quaternary ammonium salt antimicrobial agents. Although QACs have
been extensively studied and applied, it should not be ignored that
there are also have some problems, such as high toxicity, high volatility
and short duration of potency (Sütterlin, Alexy, & Kümmerer, 2008;
Zhang et al., 2015). Recently, polymeric quaternary ammonium com-
pounds (PQACs) have attracted increasing attention duo to their higher
biosafety and longer-term activity than that of QACs (Jiao et al., 2017;
Muñoz-Bonilla & Fernández-García, 2012; Ramos, Forcada, & Hidalgo-
Alvarez, 2014). Among them, quaternized chitosan has long been a
research hotspot because it not only possesses the typical properties of a
quaternary ammonium salt, but also maintains the original good
properties of chitosan.
The quaternary ammonium salt of chitosan is mainly prepared by
direct quaternization and indirect quaternization. For example, the
common method for quaternizing the amino groups of chitosan is by
treating chitosan with a halogenated alkane under alkaline conditions
(Curti, de Britto, & Campana-Filho, 2003). Another approach is that the
amino group on chitosan reacts first with aldehyde, then is reduced by
sodium cyanoborohydride or sodium borohydride and finally reacted
with haloalkane to obtain the product (Chethan et al., 2013; Liu et al.,
2018; Tabriz et al., 2019; Wei et al., 2019). The advantage of this
method is that quaternized chitosan products with different alkane
substitutions can be obtained (Fig. 1A). The indirect quaternalization
approach refers to the introduction of small molecules bearing qua-
ternary ammonium groups including N-(3-chloro-2-hydroxypropyl)
trimethyl ammonium chloride (N. A. Mohamed et al., 2013), glycidyl-
trimethylammonium chloride (Shagdarova, Lunkov, Il'ina, & Varlamov,
2019), (3-bromopropyl) trimethylammonium bromide (de Oliveira
Pedro et al., 2013), (5-bromopentyl) trimethy-lammonium bromide (de
Oliveira Pedro, Schmitt, & Neumann, 2016), and so on into chitosan
molecules (Fig. 1B). Additionally, click chemistry is an ideal method for
introducing quaternary ammonium salts into chitosan molecules. `The
click reaction has been widely applied in the chemical modification of
polysaccharides due to its advantages of high efficiency and selectivity
(Meng & Edgar, 2016). For example, Tan et al. reported one kind of
cationic chitosan derivative containing 1,2,3-triazole and N,N,N-tri-
methyl groups via an azide-alkyne click reaction, which exhibited en-
hanced water solubility and antifungal activities (Tan, Zhang et al.,
2018).
There are two major advantages of quaternized chitosan over the
parent chitosan. After quaternization of chitosan, it becomes a more
cationic macromolecule polymer with a permanent positive charge,
which correspondingly leads to an increase in solubility and activity
(Chethan et al., 2013; Chi, Qin, Zeng, Li, & Wang, 2007; Mi et al.,
2018). For example, Wang et al. reported a series of O-quaternary
ammonium salt-chitosans (QAS-CS), and found that all QAS-CSs are
soluble not only in water, but also in organic solvents such as methanol,
ethanol, DMF and DMSO. Moreover, structure-activity relationship
studies have shown that alkyl chain length and degree of substitution
(DS) are the key factors affecting the antifungal activity of chitosan
derivatives. Among them, three derivatives having a medium length
alkyl chain and a high degree of substitution showed fungicidal activity,
which could inhibit 100 % of the growth of Aspergillus and Canidia al-
bicans at a concentration of 100 ppm. In contrast, chitosan and BNQAS-
CS showed fungistatic activity even at the high concentration of
500 ppm (Wang et al., 2016). The above results indicate that whether
chitosan derivatives have fungicidal effects depends on various factors
including the DS, derivatization groups, and the tested strains. Sa-
jomsang et al. prepared a kind of water soluble quaternized chitosans
and assayed their antifungal activity against T. rubrum, T. menta-
grophyte, andM. gypseum. It was indicated that antifungal activity of the
chitosan derivatives was affected by the chemical structure, DS and
hydrophobic/hydrophilic balance. Moreover, it was proved that in-
troduction certain kinds of quaternary ammonium substituents into
chitosan backbone was effective in improving antifungal properties
(Sajomsang, Gonil, Saesoo, & Ovatlarnporn, 2012). More reports on the
antifungal activity of quaternary ammonium salts of chitosan are shown
in Table 1.
2.2. Introducing quaternary ammonium-like salt groups
In addition to the study of chitosan quaternary ammonium salts,
analogues of these salts such as pyridinium and quaternary phospho-
nium salts have shown increasing attention in recent years (Li et al.,
2013; Tan, Li et al., 2018; Zhang et al., 2018).
It was proved that N-substituted pyridinium salts possess a broad
range of activities such as antiviral, antibacterial, and antifungal ac-
tivities (Hao, Qin, Zhang, Li, & Zhang, 2019; Sowmiah, Esperança,
Rebelo, & Afonso, 2018). In addition, it can be easily dissolved in water.
Generally, pyridinium salts are introduced into chitosan by amide bond
ester bonds or Schiff bases. To exert synergistic antifungal activity,
pyridine rings of chitosan pyridinium salts are usually linked to benzene
rings, thiazole rings or other active groups (Fig. 2). In 2010, Li et al.
first reported the synthesis and antifungal properties of chitosan pyr-
idinium salts (Li, Guo, & Jiang, 2010). It was found that only the
chitosan derivative bearing pyridinium salts exhibited favorable water
solubility. If a substituted phenyl is introduced into the pyridine ring,
the solubility of the chitosan derivative will significantly decrease due
to the introduction of hydrophobic groups. Subsequent antifungal tests
showed that the pyridinium salt group could synergize with chitosan
and significantly improve its activity (Table 2). For example, the chit-
osan derivatives exterted significantly enhanced antifungal activities
against C. cucumerinum and M. fructicola, and the inhibitory rate of
CHPACS, and BHPACS can reach 100 % at 500 μg/mL, which is much
higher than that of chitosan. This indicates that the derivatives have
strong fungicidal activity. However, the antifungal activity of the
chitosan derivatives was greatly affected by the tested strains. For pa-
thogenic fungus C. lagenarium and F. oxysporum, the chitosan deriva-
tives exhibited fungistatic effect, which did not show significant im-
proved antifungal properties compared to chitosan.
The structures of quaternary phosphonium salts are similar to those
of quaternary ammonium salts. Quaternary phosphonium salts have
been investigated and considered as potential next-generation cationic
fungicides. First, quaternary phosphonium salts have structures similar
to those of quaternary ammonium salts. Moreover, it is reported that
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quaternary phosphonium salts have better antimicrobial activity and
biocompatibility than quaternary ammonium salts because the phos-
phonium groups are more highly positively charged than the ammo-
nium groups (Guo et al., 2014; Li et al., 2017; Wang, Xu, Guo, Peng, &
Tang, 2011). Therefore, the introduction of quaternary salt groups to
chitosan has recently attracted interest (Qian, Xu, Shen, Li, & Guo,
2013; Sajomsang, Ruktanonchai, Gonil, & Warin, 2010; Zhu et al.,
2016). Guo et al. reported the preparation and antibacterial activity of
N-triphenyl phosphonium chitosan (Guo et al., 2014). Then Tan et al.
succeeded in preparing a class of chitosan derivatives with quaternary
phosphonium group (Fig. S3 in Supplementary data). And first de-
scribed their potential applications as antifungal agents (Tan et al.,
2017). These chitosan derivatives were found to have significantly
enhanced solubility and antifungal efficiency compared with that of
chitosan. The results indicated that quaternary phosphonium groups
are very important for enhancing the antifungal activity. For example,
in comparison with chitosan, both the obtained chitosan derivatives
TCPACSC and TPPACSC exhibited significantly enhanced antifungal
activities against three tested crop pathogens. In particular, TPPACSC is
more active against C. lagenarium with MIC values of 0.05mg/mL.
However, research on chitosan quaternary ammonium salts is relatively
rare and requires further study.
2.3. Introducing polyamino groups
It is known that amino groups of chitosan are related to the
Fig. 1. Common methods to synthesis of quaternized chitosan under direct quaternalization (A) and indirect quaternalization (B).
Table 1
Antifungal properties of some quaternary ammonium salts of chitosan.
Sample Molecular weight Solubility DS Antifungal activitya References
CH-Pentyl 20.1 kDa n.d 64.9 Aspergillus flavus (MIC: 500 μg/mL) de Oliveira Pedro et al. (2013)
C12QAS-CS 4.9 kDa H2O
(51mg/ mL)
29.1 Aspergillus(100%)
Canidia,albicans(100%) at 100 μg/mL
Wang et al. (2016)
NCHPDCS 700 kDa n.d 38.6 B. cinerea Pers
(86.7 %) at 1000 μg/mL.
Guo et al. (2007))
N-quaternized 6oxychitosan 1600 kDa H2O
(10mg/mL)
13.8 P. hibernalis(72.8%)
at 400 μg/mL
Gao et al. (2018)
HACTFA 200 kDa n.d 71.39 C.lagenarium (96.57%)
B. Cinerea (86.57%)
P. asparagi (90.45%)
at 1000 μg/mL
Mi et al. (2018)
4CBCTCS 200 kDa H2O
(1mg/mL)
51 F. oxysporum (88.16%)
P. asparagus (93%)
at 1000 μg/mL
Zhang et al. (2018)
a % indicated the Antifungal Index (%), while minimum inhibitory concentration (MIC) is expressed as μg/mL; n.d.—not determined.
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antifungal activity, most likely because of interactions between the
positively charged ammonium groups and the negatively charged
fungal cell membranes. Therefore, there is no doubt that the number of
amino groups in the chitosan molecule is critical for its antifungal ac-
tivity. However, the reality is that there are only C2 free amino groups
in the chitosan structure, which limits the improvement of its antifungal
activity. Therefore, increasing the number of amino groups in chitosan
may be a promising option to improve its antifungal activity of chit-
osan. Fortunately, it is possible to increase the number of amino groups
in chitosan by converting hydroxyl groups at the C3 and C6 positions to
amino groups.
In general, there are mainly two main methods used to prepare
chitosan derivatives bearing amino groups: (i) Introduction of amino-
containing side chains to the chitosan backbone. For example,
Mohamed and El-Ghany prepared a series of modified chitosans with an
aminohydrazide group at the C6-position by a four-step reaction. It was
demonstrated that the incorporation of aminohydrazide groups is very
effective in improving the antifungal activity of chitosan. In particular,
the derivative 4/MWCNT1 displayed antifungal activity against C.
neoformans that was close to that of the positive control drug ampho-
tericin B (Mohamed & Abd El-Ghany, 2018). In 2015, Tiera’s group
reported synthesis of amphiphilic chitosan derivatives with diethyla-
minoethyl(DEAE) (Fig. S4 in Supplementary data). The inhibition
results show that the attaching DEAE groups alone can significantly
increase the solubility of chitosan at a neutral pH. However, this
modification does not significantly improve antifungal activity of
chitosan, and the hydrophobic Dod groups introduced later can sy-
nergize with the DEAE to obviously increase the antifungal activity of
CS against A. flavus (Fig. S5 in Supplementary data) (Gabriel, Tiera, &
Tiera, 2015). More recently, a series of chitosan derivatives of various
Mw and fixed contents of DEAE and hydrophobic groups were reported
by the same lab to study the mechanism of the antifungal properties
against A. flavus (Dias et al., 2018). Similarly, the introduction of DEAE
groups alone did not significantly improve the antifungal activity of
chitosan, but the subsequent hydrophobic modification of chitosan with
dodecyl groups improved the antimicrobial activity accordingly. It was
found that a lower Mw derivative (DEAE-CH8-Dod) was more effective,
completely inhibiting the growth of Aspergillus flavus at 1.0 g/L.
However, for chitosan and its hydrophilic derivative DEAE-CH, no in-
hibitory effect was observed at the same concentration. Obviously, the
structural modification has brought fungicidal effect to chitosan. It was
inferred that amphiphilic chitosan derivatives can strengthen the in-
teraction with fungal cell walls and thus markedly enhance the anti-
fungal activity of chitosan. In addition, the results of the inhibition
mechanism studies show that the amphiphilicity of the chitosan deri-
vatives contributes to the electrostatic targeting of hydrophilic
Fig. 2. Some representative chemical structures of chitosan pyridinium salts.
Table 2
Antifungal properties of some quaternary ammonium salts of chitosan.
Sample Molecular weight Solubility DS(%) Antifungal activitya References
BHPACS 200 kDa slightly water soluble n.d M. fructicola (100%)
C.cucumerinum(100 %)
at 500 μg/mL
Li et al. (2010)
MTPCTS 70 kDa n.d 35.7 P. asparagi (82.5%)
C. lagenarium (75.3%) at 1000 μg/mL
Li et al. (2013)
N,O-quaternized chitosan 200 kDa n.d 92.6 F. oxysporum (94.5 %)
fusarium(99.6 %)
at 1000 μg/mL
Wei et al. (2018)
Chitosan pyridinium salts 200 kDa Water soluble 80 C.lagenarium (98.44%)
W. fusarium (79.16%)
at 1000 μg/mL
Tan, Li et al. (2018)
a % indicated the Antifungal Index (%), while minimum inhibitory concentration (MIC) is expressed as μg/mL; n.d.—not determined.
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components and facilitates strong interactions with hydrophobic small
molecules present in the cell wall (Fig. 3).
(ii) Reduction reaction of 6-deoxy-6-azido chitosan to obtain 6-
deoxy-6-amino chitosan or SN reactions of 6-deoxy chitosan with var-
ious amines (Fig. 4). Early in 2004, Satoh et al. first reported the pre-
paration of 6-amino-6-deoxychitosan (Satoh et al., 2006). It was proved
that 6-deoxy-6-tosyl chitosan or 6-deoxy-6-halogeno chitosan is a very
good starting material for SN reactions (Hu et al., 2016; Tan, Li, Dong,
Wei, & Guo, 2016). Thus, they can easily react with various amines to
obtain novel C6 substituted amino chitosan. Moreover, 6-deoxy-6-tosyl
chitosan and 6-deoxy-6-halogeno chitosan are both important inter-
mediates preparing 6-deoxy-6-azido chitosan, which can yield terminal
primary amines via Staudinger reaction and Staudinger ligation (Fox &
Edgar, 2012; Koshiji et al., 2016; Luan et al., 2018). However, it is
necessary to use triphenylphosphane and remove the resulting triphe-
nylphosphaneoxide, which is not very environmentally friendly. Al-
ternatively, 6-deoxy-6-amino chitosan could also be prepared by re-
duction of 6-deoxy-6-azido chitosan with LiAlH4 or NaBH4 (Yang et al.,
2015).
For 6-amino-6-deoxychitosan, amino groups are present in both the
C2 and C6 positions of the sugar unit, so it has a higher positive charge
density than that of chitosan under acidic conditions. Previous studies
reported by Du’s group have shown that 0.1 % 6-amino-chitosan can
effectively inhibit the growth of A. niger, while the same concentration
of chitosan has no antifungal activity. In addition, unlike chitosan,
which exhibits antifungal activity only under acidic conditions, 6-
amino-chitosan exhibited an inhibitory effect on A. niger under neutral
conditions (Yang et al., 2012). Recent studies by Luan et al. showed that
6-amino-chitosan(NCS) not only had antifungal activity, of which the
inhibitory effect on four tested plant pathogenic fungi was 20 % higher
than that of chitosan, but also had good antioxidant properties (Luan
et al., 2018).
Considering that the amino group of chitosan is the structural basis
of its protonation, our group recently designed and developed another
new strategy to increase the number of amino groups recently. That is,
on the one hand, we introduced polyamines to increase the protonation
potential of chitosan and, at the same time, combined electron-with-
drawing groups such as phosphoryl groups to increase the positive
charge of on the derivatives. In addition, studies have shown that
phosphoryl groups can improve the antimicrobial activity and water
Fig. 3. A) Structure of the amphiphilic chitosan derivatives; B) A. flavus under different treatments under a laser confocal scanning microscope (labeled with DAPI as
a control); C) Schematic diagram of the amphiphilic DEAE-chitosan adsorption on cell wall and cell membrane and its interaction with their chains and aggregates.
Reprinted with permission from Dias et al. (2018).
Fig. 4. Common synthetic route of 6-amino-6-deoxychitosan and poly-amino chitosan.
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solubility of chitosan (Jayakumar, Reis, & Mano, 2006; Shanmugam,
Kathiresan, & Nayak, 2016). Based on the above hypothesis, chitosan
derivatives bearing both polyethylamino and diethoxy phorphoryl
phosphoryl groups were prepared to study the synergistic effects.
Subsequent activity tests showed that the introduction of polyamines
and phosphoryl groups not only improved the antimicrobial activity of
chitosan, but also allowed its low toxicity to be maintained (Fan et al.,
2018).
2.4. Introducing peptides /amino acids
Positively charged antimicrobial peptides (AMPs)/amino acids have
shown promising applications as potential antimicrobials due to their
high bioactivity and good biocompatibility (Ciumac, Gong, Hu, & Lu,
2019; Pfalzgraff, Brandenburg, & Weindl, 2018; Pinheiro da Silva &
Machado, 2012). Interestingly, AMPs with a net positive charge, were
thought to be similar to chitosan in term of displaying their selective
antimicrobial activity via the disruption of cell membrane integrity.
However, in addition to the excellent activity of AMPs against drug-
resistant microorganisms, their hemolytic toxicity and cytotoxicity of
AMPs to mammals should not be ignored (Maria-Neto, de Almeida,
Macedo, & Franco, 2015). To address this problem, there is a growing
interest imparting AMPs with the versatility of polysaccharides to re-
duce the toxicity (Barbosa, Vale, Costa, Martins, & Gomes, 2017;
Sahariah, Sørensen et al., 2015). In particular, chitosan is thought to be
an ideal material to use for conjugation with AMPs due to its high
biocompatibility (Pranantyo, Xu, Kang, & Chan-Park, 2018). Therefore,
some recent studies have attempted to obtain new conjugates by cou-
pling chitosan with peptides/amino acids to study whether they have
synergistic effects (Kim et al., 2016; Patrulea et al., 2016). For instance,
amino acids with hydrophobic, hydrophilic, cationic, anionic char-
acteristics including alanine, isoleucine, lysine and so on have been
grafted with chitosan to evaluate the antimicrobial activities (Fig. 5).
Chitosan peptide/amino acid conjugates are usually obtained by direct
condensation of the carboxyl groups of the amino acids with amino
groups of chitosan to form amide bonds. In the process, 1-ethyl-3-(3-
dimethylaminopropyl)-carbodiimide (EDC) and N-hydroxysuccinimide
(NHS) are often used to activate the carboxyl groups of amino acids in
the reaction process (Zhou et al., 2019). To avoid side reactions and
reduce reaction steric hindrance, some spacer molecules are often used
in the coupling process (Table 3) (Denora et al., 2016; Petrin et al.,
2019). In some cases, to prevent amino acids from self-polymerization
in the presence of EDC, the primary amino groups of amino acids will
be protected in advance (Muhsin et al., 2014).
In recent years, a biomimetic strategy inspired by the structure of
bacterial peptidoglycan has been very popular in the design and
synthesis of chitosan-peptide conjugates (Svendsen, Grant, Rennison,
Brimble, & Svenson, 2019; Takahashi, Caputo, Vemparala, & Kuroda,
2017). The newly obtained cationic peptide-polysaccharides with a
peptidoglycan-mimetic structure, have been proven to display en-
hanced biocompatibility while still retaining the antimicrobial efficacy
(Fig. S6 in Supplementary data). The coupling methods of AMPs and
chitosan usually include copolymerization, condensation and click re-
action. Linear chains of linkers are utilized in most cases. For example,
Li et al. reported the synthesis of two series of peptidopolysaccharides
namely chitosan- graft –polylysine and chitosan-graft-poly(lysine- ran
-phenylalanine) via ring-opening polymerization (Li et al., 2012). Pa-
trulea et al. described the preparation of RGDC-functionalized chitosan
conjugate by employing a modified sulfo-SIAB method. It was proved
that the presence of a diaminohexane (DAH) spacer allows for better
control of peptide grafting (Patrulea et al., 2016). In 2015, a kind of
anoplin–chitosan C2 amino substituted conjugates through click con-
jugation were prepared and reported. The authors believed that it was a
great importance of coupling peptide on C2 amino of chitosan for
maintaining the antimicrobial activity. And they successfully developed
a method for performing near-completely selective N-modification of
chitosan conjugates via tert-butyldimethylsilyl (TBDMS) protection
(Sahariah, Sørensen et al., 2015). Although the main coupling site of
Fig. 5. Some representative chemical structures of chitosan amino acid conjugates.
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chitosan peptide is C2 amino, it is still controversial whether 2-position
substitution is the most suitable one. Some opinions hold that the amino
acid residues in C2 amino-substituted of chitosan differ greatly from
those in bacterial peptidoglycans in C3 hydroxyl group. It is argued that
the better choice should be that the peptide is linked to the hydroxyl
group of chitosan. And in the very recently, Pranantyo and coworkers
reported C2 amino and C6 hydroxyl substituted chitosan antimicrobial
CysHHC10 peptide conjugates via thiol-maleimide “click” chemistry
and compared their activities (Fig. S7 in Supplementary data). It was
found that C6 substituted chitosan peptide showed higher activity of
than that of C2 substituted. And it was inferred that the existence of C2
free amino group may have a great influence on the activity (Pranantyo
et al., 2018).
Before discussing and summarizing the antifungal activity of chit-
osan peptide (amino acid) conjugates, it should be pointed out that the
above strategies are mainly aimed at antibacterial chitosan peptide
(amino acid) conjugates. This is because the current research on the
antibacterial activity of chitosan peptide conjugates is far more in-depth
and sufficient than that on the antifungal activity. However, some
studies have also proven that chitosan derivatives containing cationic
groups usually possess both antifungal and bacteriostatic activities.
Therefore, the above modification strategies are generally applicable to
antifungal chitosan peptide conjugates as well. For example, Li et al.
reported a new class of cationic peptidopolysaccharides such as chit-
osan- graft –polylysine(CS-g-Kn) and chitosan-graft-poly(lysine-ran-
phenylalanine) (CS-g-Kn Fn) by copolymerization of α-amino acids on
chitosan (Li et al., 2012). It was found that the antimicrobial activity
was influenced by the cationic charge, hydrophobicity and molecular
weight. In general, the activity of CS-g-Kn was higher than that of CS-g-
KnFn. All tested CSg-Kn samples displayed excellent broad-spectrum
activity against common clinical bacteria and fungi and had high se-
lectivity for mammalian red blood cells. This result also clearly de-
monstrated that the hydrophobicity of chitosan and cationic lysine acid
play a synergistic antimicrobial role (Table S1 in Supplementary data).
The cationic charge of lysine and the hydrophobicity of the chitosan
backbone may help improve the efficiency of the graft copolymer. And
it can be also found that the chitosan derivatives of the same type have
very different activities (MIC from 5 μg/mL to exceed 2500 μg/mL),
which imply that even small changes in structure will have a huge
impact on the activity. Among these derivatives, CS-g-K16 showed the
best antifungal activity. It is speculated that CS-g-K16 can exert a fun-
giicidal effect by penetrating the cell wall and destroying the microbial
membrane.
2.5. Introducing guanidine groups
Guanidine, considered one of strongest organic bases, imparts a
great cationic character at physiological pH. The unique structural
characteristics of guanidine enable it to form non-covalently interac-
tions with some negatively charged components such as phosphates on
the cell surface of microbial cell (Amita & Sanjay, 2013). Coupling
guanidine side chain with the polymer skeleton can increase its positive
charge, which would lead to improved aqueous solubility and poten-
tially enhanced antimicrobial activity (Gorbunova, Lemkina, &
Table 3
Coupling strategy of commonly used in chitosan peptide/anmino acid conjugates.
Peptide Linker Methods of conjugation Reference
polylysine / Copolymerization Li et al. (2012)
Anoplin peptide azidoacetyl Click chemistry Sahariah, Sørensen et al. (2015)
LED 209 Substituted aminobenzoic acid EDC/NHS Zhou et al. (2019)
RGDC peptide 1,6-hexanediamine Modified sulfo-SIAB Patrulea et al. (2016)
CysHHC10 peptide maleimidohexanoic Thiol-maleimide “click” conjugation Pranantyo et al. (2018)
Fig. 6. Typical strategy for the synthesis of guanidinylatzed chitosan.
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Borisova, 2018). Therefore, guanidine containing polymers are of great
interest and have been investigated as potential antimicrobial materials
in recent years (Qian, Guan, He, & Xiao, 2008; Qian, Xiao, Zhao, & He,
2011). Among them, guanidinylated chitosan could be expected to
serve as an ideal material for antimicrobial application due to their high
water solubility, rapid microbicidal properties, and low toxicity (Izawa,
Kinai, Ifuku, Morimoto, & Saimoto, 2019; Lahmer, Williams, Townsend,
Baker, & Jones, 2012; Salama, Abdel Aziz, & Sabaa, 2018; Su et al.,
2016; Sun et al., 2010; Xiao, Wan, Zhao, Liu, & Zhang, 2011).
The synthesis of guanidinylated chitosan generally includes direct
and indirect guanidinylation methods (Fig. 6). For direct guanidinyla-
tion, the preparation usually proceeds by participation of guanidiny-
lating reagents including chlorcyan, aminoiminomethane sulfonic acid,
cyanamide, 1-amidinopyrazole hydrochloride, and so on. For example,
Hu et.al firstly reported guanidized chitosan by the reaction of ami-
noiminomethane sulfonic acid (AIMSOA) with chitosan (Hu et al.,
2007). However, it was concluded that the degree of substitution (DS)
of chitosan is not very high (in the range of 0.25–0.30) based on the
results of elemental analysis, even if the dosage of AIMSOA was in-
creased, the DS does not increase significantly. This result may because
in the reaction process of reaction, as the pH value of the system de-
creases, it is not conducive to the guanidinylation reaction. Guanidine
functionalized chitosan can also be synthesized by the reaction of
chitosan with cyanamide in aqueous phase (Salama, Saad, & Sabaa,
2017, 2018; Zhai et al., 2011). However, due to the hydrolysis of cy-
anamide in water, the excessive amount of cyanamide is required,
which makes workup difficult and the DS of the desired chitosan de-
rivatives prepared by this method is also not very high. There was a
great challenge to prepare guanidine-based chitosan with full sub-
stitution by conventional methods. In view of this, some researchers
tried to adopt protective group strategy to achieve good control of the
reactions and finally successfully prepared completely guanidinylatzed
CS (Sahariah, Óskarsson, Hjálmarsdóttir, & Másson, 2015). Although
this method greatly improves the DS of chitosan, but it also leads to the
increase of reaction steps and the complexity of synthesis because the
reaction involves protection and deprotection steps. For indirect gua-
nidinylation, the general method is to couple the reagent containing
guanidine group including arginine, para-biguanidinyl benzonic acid, 1-
(3-(dimethylamino)propyl)guanidine, and so on to the amino group of
chitosan. In particular, chitosan arginine conjugates have attracted
considerable attention because of the guanidine group of arginine side
chains which is similar to the characteristic structure of many anti-
microbial peptides (AMPs) (Lahmer et al., 2012; Su et al., 2016; Xiao
et al., 2011).
At present, the antimicrobial activity of guanidinylatede chitosan
has been widely reported, but the reality is that the current studies are
still primarily focused on the effect of inhibiting bacteria. There are
very few reports about on the antifungal activity of guanidinylated
chitosan, which is similar to the chitosan peptide conjugate discussed
above. So far, to the best of our knowledge, only one study reported by
Salama et al. (2017). It was found that the inhibitory effect of the
chitosan derivatives for all tested fungi was significantly improved in
comparison with that of plain chitosan. Among these chitosan deriva-
tives, ChG displayed the best antifungal properties against all tested
fungi with MIC values range from 0.49 to 3.9 μg/mL, even comparable
to that of positive control amphotericin B drug against S.recemosum.
However, the author did not clarify whether the derivatives exerted
fungicidal or fungistatic effects. As is known to us, the most commonly
used method for judging fungicidal or fungistatic effects is the MFC
(minimal fungicidal concentrations)/MIC ratio method (Borman et al.,
2017; Meletiadis et al., 2007). It is generally considered fungicidal
when the value≤4 and fungistatic when the value＞4. Therefore, it is
necessary to determine MFC in subsequent studies in order to clarify the
antifungal mechanism.
2.6. Physical/ionic strategies
In general, the chemical modification stratiges of chitosan described
in the previous section requires multi-step chemical reaction and use of
organic solvents that might affect the physical properties of anti-
microbial materials and ultimately their biological functions. More
importantly, the single-component chitosan derivative cannot meet the
antimicrobial needs in some special environments. For example, most of
the above-mentioned chitosan derivatives play antifungal effect in a
solution state, which limits their applications in in preventing water
treatment systems, antimicrobial surfaces, dental and medical devices
associated infections. It has been confirmed that the formation of pa-
thogenic fungal biofilm is one of the key factors of fungal resistance
(Lynch & Robertson, 2008). Fungal biofilm-associated has recently
become a serious clinical problem, which poses a fatal threat to im-
munocompromised patients (Chandra & Mukherjee, 2015; Desai,
Mitchell, & Andes, 2014; Gupta, Daigle, & Carviel, 2016; Suleman,
Archer, Cochrane, & Percival, 2014). Fungi like Candida albicans can
produce biofilms during colonization and infection (Chandra et al.,
2001; Gulati & Nobile, 2016; Nobile & Johnson, 2015). Biofilm med-
iates adhesion to host tissues and medical devices, and protects fungi
from attacks by the host immune system and antifungals.
Therefore, in addition to the conventional chemical modification,
physical / ionic strategies can also be used to enhance the antimicrobial
effect by changing the surface morphology and properties of the chit-
osan based antifungals. For example, chitosan can form a strong com-
plex with heavy metals such as gold, silver, copper or metal oxides due
to the free amino and hydroxyl groups present in its backbone.
Therefore, the most common strategy for enhancing the antimicrobial
properties of chitosan is to use it in combination with heavy metal
metals (oxides) and their nanoparticles (Bui, Park, & Lee, 2017; Il’ina,
Shagdarova, Lun’kov, Kulikov, & Varlamov, 2017; Moussa, Tayel,
Alsohim, & Abdallah, 2013). Additionally, regarding to the design of
antimicrobial surfants, a polyelectrolyte multilayer membrane (PEM)
made by layer-by-layer (LbL) technology can serve as a multifunctional
platform. There are some studies in LbL entrapment of AMPs and other
active ingredients within chitosan polyelectrolytes on textiles and mi-
crospheres for oral drugs (Gomes, Mano, Queiroz, & Gouveia, 2015;
Guzmán, Mateos-Maroto, Ruano, Ortega, & Rubio, 2017; Huang, Zhang,
Cheng, & Xiao, 2019; Jung, Li, Yeh, Ren, & Sun, 2019). To design an-
timicrobial surfaces and interfaces, there are three main strategies to
achieve this goal: anti-adhesion, contact killing, and biocide leaching
strategies (Adlhart et al., 2018; Kaur & Liu, 2016; Swartjes et al., 2015).
In the first method, the goal is to reduce the ability of bacteria / fungi to
adhere at an early stage. This method usually relies on the use of su-
perhydrophobic surfaces. The second method is a contact killing
strategy, which attempts to immobilize active molecules (such as qua-
ternary ammonium or antimicrobial peptides). And it will become ac-
tive when contacted. For example, Jiang et al. developed a new fungal
repellent strategy based on Candida favors hydrophobic surfaces (Jiang,
Yeh, Wen, & Sun, 2015). And they found that surface of the PMMA discs
modified by TMC/SA multilayers reduced the adhesion of fungal cells
and effectively prevented the formation of biofilm. This discovery
provides a new option for the development of drug-free biofilm-re-
sistant healthcare materials. Although contact active surfaces have the
advantage of long-term effect, they may not completely kill the pa-
thogens unless direct contact, especially to the planktonic state of pa-
thogens, and show a fungistatic effect. In the last (and oldest) principle,
antibiotics, silver as well as other antifungal agents loaded into the
bioactive coating, can release the active molecules and kill planktonic
pathogens. The fungicidal effect is fast and efficient. For instance, Re-
giel-Futyra et al. described the preparation of chitosan–ascorbic
acid–silver nanocomposites (Regiel-Futyra et al., 2017). It was found
that the nanocomposites exhibited a great bactericidal and fungicidal
potential against the tested pathogens as well as inhibition of biofilm
formation. Moreover, chitosan–silver nanocomposites showed reduced
Y. Qin, et al. Carbohydrate Polymers 236 (2020) 116002
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cytotoxicity on mammalian, which may be promising antimicrobials
candidates However, limitations include short duration of sustained
release, potential toxicity and drug resistance. In order to achieve better
antifungal effects, the latter two functional principles are sometimes
combined to achieve a synergistic effect, such as by embedding a fun-
gicidal substances in a surface with a contact active function.
As mentioned avove, among these antimicrobial strategies, con-
trolled release may be a good strategy to inhibit biofilm formation,
while the contact kill strategy has its limitations because it requires
direct contact with pathogenic fungi. In the case of biofilm formation,
the application of chitosan alone may not be the best choice. It might
me a better option to combine chitosan with other active ingredients to
exert the best effect.
3. Applications
Although chitosan has proven antifungal properties, it can only
dissolve in dilute acid and display antimicrobial activity only under
acidic conditions. However, in fact, microorganisms usually live in
neutral pH, and many enzymatic biochemical reactions related to life
activities are often carried out in aqueous phase. This greatly limits the
application of chitosan. On the contrary, many cationic chitosan deri-
vatives obtained by structural modification of chitosan often shows
good solubility in a wide pH range as well as satisfactory antifungal
activity. In addition, the physical / ionic strategy further enhances the
antifungal effect of chitosan and endow it new functions. All these
performance changes greatly expand its applications and some re-
presentative examples are summarized in Table 4. Considering that
there are already some excellent review articles published recently
about the applications of chitosan and its derivatives, this article will
mainly focuses on several specific application areas including wound
dressing, health facility disinfection, antimicrobial textiles, and food
packaging materials.
3.1. Wound dressings
Chitosan is known for its hemostatic and antimicrobial properties,
which are especially effective for wound management (Dai, Tanaka,
Huang, & Hamblin, 2011; Khan & Mujahid, 2019). As a hemostatic
agent, chitosan helps to naturally coagulate and stop nerve endings,
thereby reducing pain. Chitosan is a positively charged polymeric
amine and can attract negatively charged ions as well as pathogens in
blood and exudate. Due to the similar chemical structure of chitosan
and cellulose, the two are often mixed at the polymer and fiber levels.
This hybrid allows manufacturers to design products with the required
performance at a lower cost. Chitosan-based hemostatic agent is prob-
ably one of the most successful commercial product of chitosan cur-
rently developed, and there are several chitosan-based wound dressings
on the market for clinical use, including the FDA-approved and com-
mercially available Combat Gauze, Celox Rapid, ChitoGauze, and
ChitoFlex.
Recently, it was reported that zinc oxide nanoparticles were in-
corporated in the chitosan hydrogel to further increase their anti-
microbial activity. Addition of zinc oxide improved its flexibility, an-
timicrobial activity and tensile strength (Sudheesh Kumar et al., 2012).
In addition, many current researches have further improved the man-
ufacturing method of the chitosan bandage dressing to enhance its ex-
isting hemostatic potential and antimicrobial activity (Bagher et al.,
2020; Hamedi, Moradi, Hudson, & Tonelli, 2018). When integrating
some antioxidants or coupling to chitosan, the mechanical properties,
drug delivery and wound healing properties of the chitosan bandage are
improved. By loading active ingredients, it opens up new options for the
treatment of chronic wounds in diabetic foot (Moura et al., 2014).
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3.2. Health facility disinfection
Generally, cationic chitosan derivatives not only has good water
solubility and antifungal activity, but also maintains the advantages of
good biocompatibility and biodegradability of chitosan. Moreover, it
can also be processed by copolymerization, crosslinking, blending,
forming complex with metal ions, and so on, so as to obtain materials,
such as membranes, gels, coating, scaffolds, for different uses (Hassan,
2018; Mohamed & Abd El-Ghany, 2018; Mohamed, Elella, & Sabaa,
2015; Pranantyo et al., 2018; Tabriz et al., 2019). Among the diverse
applications of cationic chitosan derivatives to inhibit fungi, one of the
most noticeable may be its disinfection control in clinics, hospitals and
some medical environments. The prevalence of fungal infections is on
the rise due to the prevalence of immunodeficiency diseases caused by
organ transplantation, immunosuppressive therapy, built-in medical
device therapy, radiotherapy and chemotherapy, and AIDS (Aslam,
Hernandez, Thornby, Zeluff, & Darouiche, 2010; Badiee &
Hashemizadeh, 2014; Georgiadou & Kontoyiannis, 2017; Lanternier
et al., 2013). The occurrence of fungal resistance is the main reason for
the poor anti-fungal treatment (Revie et al., 2018). It’s a great challenge
to develop novel antifungal materials to prevent fungal biofilm for-
mation. A common approach to address this problem is to design sur-
faces that release biocides, such as metal ions (such as gold, silver, lead,
or arsenic) or chemicals (such as triclosan, chlorhexidine, peroxide, or
chlorine). Limitations of these methods include the short lifespan of the
biocides released and their potential toxicity. Other strategies have also
attempted to address these limitations by developing "contact-killing"
antimicrobial surfaces containing covalently attached groups, such as
cationic macromolecules containing biguanide, pyridinium or qua-
ternary ammonium salts. For example, Hoque et al. demonstrated that
N-(2-hydroxypropyl)-3-trimethylammonium chitosan chlorides (HTCC)
display rapid microbicidal kinetics by destroying the cell membrane of
resistant fungi. More importantly, the cationic chitosan derivatives
exhibit very low toxicity in vitro and in vivo (Hoque et al., 2016).
Therefore, these highly selective polymers have potential applications
in the dearth of new antibiotics for clinical pipelines. Very recently,
Jung et al. report a novel fungal control strategy based on layer-by-
layer self-assembly of amphiphilic quaternary chitosan (CS612) / so-
dium alginate (SA) multilayer coatings on PMMA-based denture bio-
materials to Controlling fungal biofilm formation. The multi-layer
coating effectively altered surface properties and prevented the for-
mation of fungal biofilms, suggesting that CS612 / SA LBL multilayers
had fungal repellency. In addition, the multi-layer coating also has good
cell compatibility and stability, which indicates that this new type of
coating may have great potentials for controlling fungal biofilm for-
mation in clinically applications (Jung et al., 2019). Although these
surfaces can inhibit microorganisms upon contact, their effectiveness is
inherently limited to cells in direct contact with the microorganisms.
Therefore, in order to exert the synergistic antifungal effect, it will be a
better choice to use it in combination with the slow-release sterilization
strategy.
3.3. Antimicrobial textiles
Antimicrobial-treated fabrics play a key role in the protection and
treatment of appropriate skin injury care. Among many antimicrobial
finishing agents, chitosan stands out as a green and environmentally
friendly material (Morais, Guedes, & Lopes, 2016; Shahid ul & Butola,
2019). It is rich in resources and has excellent characteristics such as
moisture absorption, breathability, high reactivity, biodegradability,
adsorption, broad-spectrum antibacterial, and safety and nontoxicity.
Chitosan are often used to develop antimicrobial fabrics that are en-
vironmentally friendly, broad-spectrum antibacterial, low cost, and
comfortable to wear. Chitosan can be well combined with cellulose fi-
bers through hydrogen bonding, so it is often used for antimicrobial
finishing of cotton fabrics (Cheng, Ma, Li, Ren, & Huang, 2014; Fu,
Shen, Jiang, Huang, & Yan, 2011; Ibrahim, Eid, El-Aziz, Elmaaty, &
Ramadan, 2017; Periolatto, Ferrero, & Vineis, 2012). Similar to the
antimicrobial surface strategy mentioned above, chitosan's anti-
microbial effect in fabrics can also be divided into two types: contact
and slow-release active modes. For instance, Xu et al. successfully used
carboxymethyl chitosan (CMCTS) and silver nanoparticles to attach to
the surface of cotton fabrics by a simple atomization modification
process. The CMCTS adhesive is covalently connected to the cotton
fabric through esterification, and the Ag nanoparticles are tightly ad-
hered to the fiber surface through coordination bonds with the amine
groups of CMCTS. The results showed that the Ag nanoparticle coating
on the cotton fabric showed excellent antimicrobial and washing re-
sistance (Xu et al., 2018). Fu et al. (2011) synthesized three different
chitosan quaternary ammonium salts and used citric acid as a cross-
linking agent to finish cotton fabrics. After finishing, the antimicrobial
rates of the finished fabrics against Staphylococcus aureus and E. coli
were more than 99 % and 96 %, of which O-quaternized-N-chitosan
Schiff base has the best effect in finishing fabrics.
There has been already a commercial product based on this natural
polymer, Eosy®, the composite fiber of chitosan and viscose called
Crabyon® is also commercially available and has a long-lasting anti-
microbial effect. In addition, textiles are using chitosan-based anti-
microbials to prevent infection and / or protective and sportswear is
already on the market.
3.4. Food packaging materials
Chitosan and its derivative have broad-spectrum antifungal activity,
and can inhibit the germination of sporangia, germination tube and
mycelium growth of pathogenic fungi (Badawy, 2010; El Hadrami,
Adam, El Hadrami, & Daayf, 2010; Guo et al., 2007; Tan, Ma, Lin, Liu, &
Tang, 2013; Tan, Zhang et al., 2018; Xing, Zhu, Peng, & Qin, 2015).
At present, there have been a large number of research reports on
chitosan's antimicrobial film for fresh-keeping of fruits and vegetables
(Grande-Tovar, Chaves-Lopez, Serio, Rossi, & Paparella, 2018; K, MP, &
GR, 2019; Kaewklin, Siripatrawan, Suwanagul, & Lee, 2018;
Sangsuwan, Pongsapakworawat, Bangmo, & Sutthasupa, 2016). Studies
have found that edible film made of chitosan is an important way to
keep fruits, meat, vegetables, and fish fesh. The edible film not only
prevents the loss of original nutrients in food, but also plays a role in
increasing nutrition and some food additives such as antioxidant.
Among them, the application of controlling postharvest diseases and
preservation of fruits and vegetables attracts special attention. Infection
of pathogenic fungi and deterioration of metabolism are the main
causes of fruit decay and deterioration (Singh & Sharma, 2018;
Snowdon, 1988). To reduce fungal contamination and related fruit and
vegetable decay, antimicrobial coatings and films, especially natural
antimicrobial films such as chitosan based films are preferred in the
management and control of postharvest diseases (Campos,
Gerschenson, & Flores, 2011; González-Estrada, Chalier, Ragazzo-
Sánchez, Konuk, & Calderón-Santoyo, 2017; Grande-Tovar et al., 2018;
Romanazzi, Nigro, Ippolito, DiVenere, & Salerno, 2002; Sharma,
Barman, & Siddiqui, 2016; Valencia-Chamorro, Palou, del Río, & Pérez-
Gago, 2011). This is because most of postharvest pathogenic con-
tamination of fresh fruits and vegetables occurs mainly on their surface
(Heaton & Jones, 2008), so the application of antimicrobial film is safer
and more effective than the application of traditional small molecule
fungicides. Therefore, it is a promising preservative for fruits and ve-
getables (Figure 19) (Dutta, Tripathi, Mehrotra, & Dutta, 2009; Gian-
franco Romanazzi, Feliziani, & Sivakumar, 2018). However, when the
chitosan derivative films are used alone, there are some shortcomings,
such as poor mechanical properties of the film and short retention time
of the coating (Cazón & Vázquez, 2019; Oh & Hwang, 2013). If they are
mixed with other preservatives by using composite film, nanoparticles,
microcapsules and other technologies, they may play a synergistic role,
thus expanding their application scope (Saraji, Tarami, & Mehrafza,
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2019).
3.5. Other applications
In addition to the applications mentioned above, chitosan has many
other potential applications. For example, the incorporating of chitosan
into the polymer blend ultimately improved its strength, wettability,
resistivity, and antimicrobial activity (Abraham, Soloman, & Rejini,
2016; Lewandowska, 2015; Sionkowska, 2011). Chitosan containing
polymer composites can be used as coatings, paints, hydrogels, which
have several ranges of applications in the industry (Dutta, 2019). Ad-
ditionally, chitosan and its derivatives can also be used as drinking
water treatment agents and have been approved by the EPA (approval
number:SU834295). As a potential biocontrol pesticide, chitosan and its
cationic derivative also can be made into seed soaking agents, root
application agents, spray agents, film spreading agents, etc
(Kumaraswamy et al., 2018). Moreover, they can be used as soil
amendment to control soil-borne diseases, as seed dressing agents to
control seed-borne diseases, fruit and vegetable preservation to control
postharvest diseases (Badawy & Rabea, 2016; Betchem, Johnson, &
Wang, 2019; Fan et al., 2018; Kumaraswamy et al., 2019; Zhang, Li, &
Liu, 2011). Currently, chitosan and its derivatives have been registered
as bio-pesticides in the United States, China and other countries.
4. Challenges and shortcomings
As mentioned in the above review, the feasibility of improving the
solubility and antifungal activity of chitosan by increasing its positive
charge density has been widely investigated. Overall, these studies in-
dicate that cationic chitosan derivatives have great application pro-
spects for disinfection, postharvest disease control and preservation of
fruits and vegetables, etc. However, it should be noted that, although
good progress on antimicrobial chitosan derivatives has been made
over the past two decades, there are also a series of challenges and
shortcomings such as uncontrollable derivative quality, unclear struc-
ture-activity relationship, and potential toxicity to mammals. Most
importantly, the practical application of cationic chitosan derivatives is
progressing slowly. Most of the antifungal activity reported only re-
gards the in vitro activity. There are few reports on clinical or field in
vivo tests.
4.1. How to ensure reproducible product quality?
Unlike traditional small molecular weight therapeutics which have
a well-defined chemical structure, chitosan derivatives exhibit some
heterogeneity as with other polymers. Chitosan derivatives vary with
respect to their molecular weights, degrees of substitution, substitution
sites, and resulting structural complexity, making the controllable, re-
producible, and scalable preparation of chitosan derivatives challen-
ging (Alves & Mano, 2008; Hosseinnejad & Jafari, 2016; Khan et al.,
2017; Riaz Rajoka, Zhao, Mehwish, Wu, & Mahmood, 2019; Sahariah &
Másson, 2017; Verlee et al., 2017; Zargar et al., 2015). From the per-
spective of practical application in the future, the synthesis of deriva-
tives should be environmentally friendly, cost-effective, and easy to
manufacture at an industrial scale. However, the reality is that struc-
tures of the cationic chitosan derivatives usually vary from batches to
sources. Moreover, due to the lack of reasonable molecular design in
the design and synthesis process, the synthetic derivatives also have
problems such as structural heterogeneity, poor chemical selectivity
and poor reproducibility (Bellich, D’Agostino, Semeraro, Gamini, &
Cesàro, 2016; Carvalho, Queda, Santos, & Marques, 2016; Pillai et al.,
2009; Sajomsang, Tantayanon, Tangpasuthadol, & Daly, 2008).
Therefore, it is difficult to fabricate a chitosan derivative with re-
producible structure and appropriate properties. In addition, the
structural complexity of chitosan derivatives poses great challenges to
the characterization of their physicochemical properties. Determining
how to establish a uniform, accurate and repeatable detection method is
another problem that needs to be solved.
4.2. How to accurately determine the structure-activity relationship?
Although it is generally believed that chitosan derivatives have a
broad spectrum of antifungal activity, their activities are affected by
multiple factors including molecular weight, degree of substitution,
hydrophobicity, type of fungus, pH, etc. There have been some ex-
cellent reviews on the antimicrobial structure-activity relationships
(SARs) of chitosan derivatives (Sahariah & Másson, 2017; Verlee et al.,
2017), however, so far there appears to be no precise, universal cri-
terion to predict how the structural parameters determine the proper-
ties of chitosan derivatives. In fact, study of the SAR of chitosan deri-
vatives is far from the level of SAR research of small molecule drugs due
to the complexity of the structure of chitosan derivatives, as well as lack
of special antimicrobial methods and models. It is hard to compare and
analyze the antifungal results of the chitosan derivatives obtained by
different researchers and draw clear conclusions. There are often large
differences in activity in different studies. Some studies even have
diametrically opposite results, which makes it difficult to accurately
evaluate the structure-activity relationship of chitosan. For example,
the degree of substitution(DS) is a key factor affecting the antifungal
activity of chitosan. The antimicrobial activity of cationic chitosan
derivatives generally improves with increasing DS. However, at the
same time, the activity may also be affected by other factors such as
hydrophobicity, substitution sites or spacer (Anitha et al., 2009;
Badawy & Rabea, 2014; Chethan et al., 2013; Gabriel et al., 2015; Jung,
Kim, Choi, Lee, & Kim, 1999; Li, Tan, Zhang, Gu, & Guo, 2015; Sarwar,
Katas, Samsudin, & Zin, 2015). Furthermore, for macromolecules such
as chitosan, it is a challenge to ensure that each step in the reaction goes
to completion under heterogeneous or multistep reaction conditions.
Therefore, the subsequent DS calculation and QSAR analysis are also
complicated. All of these limitations undoubtedly hinder further de-
velopment and applications of the chitosan derivatives. To address this
problem, it may be a good choice to achieve precise synthesis of specific
DS through protection and deprotection strategies. More recently, re-
search has made good progress in this area (Sahariah, Óskarsson et al.,
2015).
4.3. How to balance activity and toxicity?
Chitosan is considered to be nontoxic, biocompatible and biode-
gradable. Research on cationic chitosan derivatives has therefore fo-
cused more on the activity, ignoring its potential toxicity. While striving
to enhance the antimicrobial properties of chitosan, a low toxicity of
chitosan derivatives should be ensured to promote their development
into practical applications. Charge density is considered to be a key
factor affecting the antimicrobial activity, selectivity and mammalian
toxicity of chitosan to pathogens and mammalian cells (Kean & Thanou,
2010; Wang et al., 2016). In general, the antimicrobial activity in-
creases as the positive charge increases. However, cations in chitosan
derivatives may also affect the toxicity. In fact, some studies have
shown that with increasing positive charge density and concentration,
the activity and toxicity of chitosan derivatives increase accordingly
(Min et al., 2018; Sahariah et al., 2014). In addition, it has been re-
ported that enhancing the hydrophobicity of the chitosan quaternary
ammonium via increasing alkyl chain length also leads to the risk of
increased hemolysis and toxicity (Sahariah, Benediktssdóttir et al.,
2015). It is speculated that the cationic chitosan derivatives may have a
charge threshold, and that once that threshold is exceeded, increasing
the positive charge density will not significantly increase the activity,
but will increase the toxicity. Therefore, it is important to maintain an
appropriate charge density for cationic chitosan derivatives to max-
imize the antifungal activity and minimize toxicity.
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4.4. Lack of in vivo activity data and unclear mechanism of action
Although research on the inhibition of bacteria and fungi by ca-
tionic chitosan derivatives has been widely reported and confirmed, it
must be acknowledged that the current studies have mainly been in the
laboratory stage over the past 2 decades, that most of the research on
antimicrobial activity as well as toxicity are in vitro, and that the tested
strains are mostly common drug sensitive strains. In contrast, there are
very few studies on the in vivo antifungal activity of cationic chitosan
derivatives in the literature, and research from clinical trials and field
trials is rarely reported. Currently there is very little data on the
pharmacodynamics, pharmacokinetics, environmental toxicology, in
vivo toxicity of the chitosan derivatives. Furthermore, information on
the stability, biocompatibility and biodegradability of cationic chit-
osan-based antimicrobial membranes, gels, and surfaces is urgently
needed. This information is vital for the accurate evaluation of a pro-
mising polymer drug in the early stage, and will primarily decide
whether it is suitable for further development.
Currently there is no single widely recognized antifungal mode of
action for chitosan and its cationic chitosan derivatives (Kong et al.,
2010; Lopez-Moya, Suarez-Fernandez, & Lopez-Llorca, 2019). For the
antifungal mechanism of chitosan, the prevailing view is that the po-
sitively charged amino group of chitosan might bind with the negative
charged substance such as phospholipids in the cell wall of the fungi via
electrostatic interactions, forming a layer of polymer membrane on the
surface of the fungi cell, changing the selective permeability of the cells,
thus blocking nutrients from entering the cells, or disrupting the cell
membrane, entering the cell, leading to inhibition of DNA/RNA and
protein synthesis (Kong et al., 2010; Verlee et al., 2017).
Most of the antifungal mechanism studies to date have only been on
the origin chitosan (Martins et al., 2018). Considering that a new
functional group is introduced into the chitosan skeleton, sometimes
introduction of a plurality of reactive groups brings about the diversity
in the structure of the chitosan derivative, and the antifungal properties
may be the result of a combination of a plurality of different groups.
Therefore, it is difficult to judge whether the antifungal mechanism of
chitosan is equally applicable to the chitosan derivatives. Accordingly,
more research is needed on the antifungal mechanism of cationic
chitosan derivatives.
5. Concluding remarks
The main purpose of this review is to highlight the recent progress
in the field of cationic chitosan-based antifungal therapeutic applica-
tions. The broad range of properties exhibited by cationic chitosan
derivatives indicates that they may have application prospects in many
areas of therapeutic need. However, before actual application, these
compounds will face a large number of long-term clinical trials or field
trials, as well as a very strict regulatory approval process, all of t which
requires detailed activity data as a support.
In the future, considering the diversity of the chitosan derivative
structure, great efforts are desirable to prepare chitosan derivatives
with well-defined structures through biological rational design and
appropriate synthetic methods. First, the structural design of chitosan
derivatives should be as simple as possible under the premise of en-
suring antifungal activity, and the synthesis of the derivatives should be
shortened as much as possible to reduce side reactions and the corre-
sponding structural uncertainty of chitosan derivatives. Additionally,
since the synthesis of small molecule compounds is more controllable
than the modification of macromolecules, it is conceivable to first
synthesize small molecule intermediate building blocks and then couple
them with chitosan. Moreover, in the process of structural modification
of chitosan, functional group protection and deprotection strategies
should be adopted to avoid side reactions and improve product sub-
stitution. In terms of antifungal activity and toxicity, it is necessary to
ensure that the chitosan sample has a clear source, uniform quality and
high purity. The strains to be tested should be representative, and in
particular, resistant strains should be selected; More importantly, the
standard physicochemical characterization methods, strict structure-
activity relationship studies, and in-depth in vitro and, in vivo anti-
fungal activity and toxicity tests are extremely important. Most im-
portantly, researchers need to assess whether the chitosan derivatives
have the potential to be developed as macromolecular drugs at an early
stage and to accurately focus on their possible scope of application,
such as oral or topical, and as a drug or as an excipient. All of these
approaches require the application of multidisciplinary techniques and
methods, and therefore require the collaboration of synthetic chemists,
physiologists, clinicians, toxicologists, etc. Nevertheless, more studies
are needed for the in-depth evaluation of cationic chitosan derivatives
to take full advantage of their therapeutic potential.
In summary, with the advancement of follow-up technologies, more
detailed information will be undoubtedly obtained about the antifungal
structure-activity relationships and mechanisms of chitosan derivatives
with target cells; It is believed that cationic chitosan-based materials
will become a powerful and effective tool for antifungal therapy.
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